We are live on ! Find out more
OGC

Oak Grove Capital Portfolio holdings

AUM $1.18B
1-Year Est. Return 84.79%
This Fund
S&P 500
This Quarter Est. Return
+13.4%
1 Year Est. Return
+84.79%
3 Year Est. Return
+236.05%
5 Year Est. Return
+282.98%
10 Year Est. Return
AUM
$447M
AUM Growth
+$89.1M
Cap. Flow
+$44.4M
Cap. Flow %
9.92%
Top 10 Hldgs %
49.61%
Holding
118
New
16
Increased
39
Reduced
36
Closed
7

Top Buys

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$6.94M
2
DKNG icon
DraftKings
DKNG
+$4.98M
3
LRCX icon
Lam Research
LRCX
+$4.88M
4
RBLX icon
Roblox
RBLX
+$4.53M
5
LUV icon
Southwest Airlines
LUV
+$4.23M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$5.83M
2
TSM icon
TSMC
TSM
+$4.78M
3
GILD icon
Gilead Sciences
GILD
+$2.48M
4
DDOG icon
Datadog
DDOG
+$1.92M
5
SLV icon
iShares Silver Trust
SLV
+$892K

Sector Composition

Rank Sector Weight
1 Technology 44.26%
2 Consumer Discretionary 9.38%
3 Healthcare 9.14%
4 Industrials 7.96%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
51
Sherwin-Williams
SHW
$84.9B
$1.31M 0.29%
4,800
ORCL icon
52
Oracle
ORCL
$402B
$1.3M 0.29%
16,700
-1,300
-7% -$102K
DIS icon
53
CALL
Walt Disney
DIS
$169B
$1.25M 0.28%
17,700
-700
-4% -$126K
EEMA icon
54
iShares MSCI Emerging Markets Asia ETF
EEMA
$834M
$1.2M 0.27%
13,000
BPYU
55
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$1.2M 0.27%
63,500
PYPL icon
56
PayPal
PYPL
$49.2B
$1.17M 0.26%
4,000
+1,900
+90% +$502K
ALB icon
57
Albemarle
ALB
$14B
$1.04M 0.23%
+6,175
New +$997K
MRNA icon
58
Moderna
MRNA
$22.3B
$987K 0.22%
4,200
+2,600
+163% +$465K
SRE icon
59
Sempra
SRE
$57.4B
$901K 0.2%
13,600
+600
+5% +$41.1K
BRK.A icon
60
Berkshire Hathaway Class A
BRK.A
$1.1T
$837K 0.19%
2
MRK icon
61
Merck
MRK
$314B
$809K 0.18%
10,400
-499
-5% -$37.1K
PFE icon
62
Pfizer
PFE
$142B
$783K 0.18%
+20,000
New +$778K
TWTR
63
DELISTED
Twitter, Inc.
TWTR
$757K 0.17%
11,000
-3,500
-24% -$215K
CRM icon
64
Salesforce
CRM
$155B
$745K 0.17%
3,050
+1,050
+53% +$242K
SBSW icon
65
Sibanye-Stillwater
SBSW
$6.26B
$736K 0.16%
44,000
+15,400
+54% +$286K
IHI icon
66
iShares US Medical Devices ETF
IHI
$3.35B
$703K 0.16%
11,676
-1,200
-9% -$69.4K
BA icon
67
CALL
Boeing
BA
$180B
$695K 0.16%
7,600
-7,500
-50% -$1.81M
B
68
Barrick Mining
B
$62.2B
$579K 0.13%
+28,000
New +$631K
XYZ
69
Block Inc
XYZ
$48.8B
$527K 0.12%
2,160
-100
-4% -$23.2K
REGN icon
70
Regeneron Pharmaceuticals
REGN
$78.7B
$525K 0.12%
940
+220
+31% +$111K
ARKG icon
71
ARK Genomic Revolution ETF
ARKG
$1.6B
$481K 0.11%
5,200
BANX
72
ArrowMark Financial
BANX
$198M
$468K 0.1%
21,281
-4
-0% -$84
SWKS icon
73
Skyworks Solutions
SWKS
$9.06B
$441K 0.1%
2,300
+600
+35% +$106K
GOOG icon
74
Alphabet (Google) Class C
GOOG
$4.59T
$439K 0.1%
3,500
-800
-19% -$95.3K
CDNS icon
75
Cadence Design Systems
CDNS
$93.1B
$438K 0.1%
3,200

Similar funds

Oak Grove Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Oak Grove Capital held 118 positions worth $447M, up 25% from $358M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Oak Grove Capital deployed $44.4M of net new capital in Q2 2021, opening 16 new positions and adding to 39 existing holdings. Its largest new stake was DraftKings: 94,455 shares worth $4.93M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $5.83M trimmed.

  • Oak Grove Capital's largest Q2 2021 buy was DraftKings: 94,455 shares worth $4.93M.
  • Oak Grove Capital added most to Xilinx Inc in Q2 2021, an estimated $6.94M increase.
  • Oak Grove Capital's biggest Q2 2021 reduction was Walmart Inc, cutting an estimated $5.83M.
  • Oak Grove Capital fully exited F5 in Q2 2021, selling an estimated $501K.
  • Oak Grove Capital's ten largest holdings make up 50% of its $447M portfolio in Q2 2021.
  • Oak Grove Capital opened 16 new positions and closed 7 in Q2 2021.
  • Oak Grove Capital's portfolio value rose 25% quarter-over-quarter to $447M.

Based on Oak Grove Capital's 13F filing for Q2 2021, filed 13 Aug 2021.